GMED Insider Trading Activity and SEC Form 4 Filings
GMED insider trading summary
Over the past 12 months, insiders at Globus Medical Inc (GMED) reported 15 sales worth $18.0M by 7 insiders and no open-market purchases on SEC Form 4. Net insider selling was $18.0M.
Latest GMED insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Ann D Rhoads | Insider | Sell | $425K (5,000 @ $85.00) |
| Sep 15, 2026 | James R Tobin | Insider | Sell | $2.2M (30,000 @ $74.58) |
| Aug 18, 2026 | Stephen T Zarrilli | Insider | Sell | $2.2M (25,000 @ $87.04) |
| Jun 5, 2026 | David D Davidar | Insider | Sell | $2.0M (25,000 @ $80.76) |
| Feb 25, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sell | $1.9M (20,000 @ $94.50) |
| Feb 12, 2026 | Kelly Huller | EVP, GC, Corporate Secretary | Sell | $877K (10,000 @ $87.67) |
| Jan 8, 2026 | Leslie V Norwalk | Insider | Sell | $202K (2,000 @ $101.10) |
| Jan 8, 2026 | Kyle Kline | Senior Vice President, CFO | Sell | $363K (3,594 @ $101.10) |
| Dec 12, 2025 | Leslie V Norwalk | Insider | Sell | $355K (4,000 @ $88.85) |
| Dec 1, 2025 | Kyle Kline | Senior Vice President, CFO | Sell | $1.7M (18,542 @ $90.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.